An Interview With James A. Fagin
In 2006, James A. Fagin was appointed Chief of Memorial Sloan-Kettering's Endocrinology Service and a member of the Human Oncology and Pathogenesis Program. His research has been instrumental in characterizing many of the genetic changes associated with the development and progression of thyroid cancer.
28th Annual Memorial Sloan-Kettering Convocation Ceremony
Memorial Sloan-Kettering's Academic Convocation recognizes and honors research as it is embodied in many individuals, including students who have earned their PhD degrees for work carried out in Memorial Sloan-Kettering's laboratories, younger Memorial Sloan-Kettering physicians, scientists, and postdoctoral research fellows, as well as established clinicians and investigators from the Center and beyond.
Outcome of Prostate Cancer Surgery Depends on the Experience of the Surgeon
According to a new study published online in the Journal of the National Cancer Institute, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.
Memorial Sloan-Kettering Team Creates Muscle Cells from Embryonic Stem Cells
A team of Memorial Sloan-Kettering investigators has reported for the first time a novel strategy to coax human embryonic stem cells (HESCs) to develop into cells that could potentially be used to repair the musculoskeletal system, including bone, cartilage, and muscle.
VEGF Trap Shows Activity in Patients with Advanced Ovarian Cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which were presented at the American Society of Clinical Oncology's annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
Unlocking the Mysteries of Cancer: A Dialogue about Cancer Risk, Genetics, and the Role of Race and Ethnicity in Cancer
On Wednesday, September 26, physicians from Memorial Sloan-Kettering Cancer Center, the Breast Examination Center of Harlem, and the Ralph Lauren Center for Cancer Care and Prevention will discuss the latest information on how genetics influence the risk of developing cancer for African Americans and Latinos.
An Update on the Diagnosis and Treatment of Lung Cancer
On Tuesday, October 23, join Memorial Sloan-Kettering Cancer Center physicians -- Raja M. Flores, of the Thoracic Service; Mark G. Kris, of the Thoracic Oncology Service; and Kenneth E. Rosenzweig, of the Department of Radiation Oncology -- for an update on the diagnosis and treatment of lung cancer. Topics will include: risk factors, screening, diagnosis, and treatment options for lung cancer.
Living Beyond Cancer Calendar
Our Living Beyond Cancer section of the Web site includes a calendar with searchable listings of upcoming survivorship workshops, support groups, and events.
